31
Mar
National Platform for Telemedicine: Agenas launches a request for proposals to set up a Public/Private Partnership
Taking advantage of the resources made available under the Next Generation EU Plan, the Italian Government has decided to launch a project for the planning, implementation and delivery of IT services facilitating access to the National Platform for Telemedicine.
3
Mar
Investing in biotech
At the end of last year, our partners Luca Gambini and Antonia Verna talked to Elizabeth Robinson, vice chairman of the board of Indaco Venture Partners, and Ciro Spedaliere, partner in Claris Ventures SGR S.p.A., about the last trends in venture capital investments in the biotech sector.
9
Feb
European Clinical Trials Regulation is now applicable: Recent updates
On January 31, 2022, EU Regulation 536/2014 on clinical trials of medicinal products for human use (“Clinical Trials Regulation” or “CTR”) finally went into effect more than seven years after its approval, but Italy is not yet ready for its application.
9
Feb
The new version of the Code of Ethics of the Italian association of pharmaceutical companies: Key developments
The Italian association of pharmaceutical companies (“Farmindustria”) released the new version of its Code of Ethics on January 19, 2022.
Some of the main changes concern i) hybrid events (art. 3.7 bis); ii) activities that pharmaceutical companies are allowed to carry out for non-prescribing HCPs (art. 3.25); iii) information provided to the public (art. 3.26); iv) interactions other than drug promotion (art. 3.28); and v) Patient Support Programs (article 4.7).
